Lianne Gensler, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
AddressLocation Required, #001
Phone415-353-2497
ORCID ORCID Icon0000-0001-6314-5336 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, Los AngelesB.S.1995Microbiology & Molecular Genetics
    University of California IrvineM.D.2001School of Medicine
    University of California, San Francisco2004 Residency, Internal Medicine
    University of California, San Francisco2005Chief Resident
    University of California, San Francisco2008Rheumatology Fellowship
    University of California, San FranciscoCertificate2008 Medicine (Advance Training in Clinical Research)
    University of California, San Francisco, CA2019Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    2012Spondylitis Association Young Investigator Award
    University of California, San Francisco2015Ira M. Goldstein Teaching award in Rheumatology
    University of California, San Francisco2015Research Mentoring Award

    Collapse Overview 
    Collapse Overview
    Dr. Lianne Gensler is a rheumatologist and serves as director of the UCSF Ankylosing Spondylitis Clinic, which is dedicated to care for this inflammatory disease.

    Gensler's primary research interest is the disease progression of axial spondyloarthritis (a category that includes ankylosing spondylitis). Her research also seeks to identify predictors of osteoporosis development in patients with systemic lupus erythematosus.

    Gensler earned her medical degree at the University of California, Irvine. She completed an internal medicine residency, chief residency and rheumatology fellowship at UCSF, and subsequently joined the medical staff in the rheumatology program.

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Effect of secukinumab versus adalimumab biosimilar on radiographic progression in patients with radiographic axial spondyloarthritis: Results from a head-to-head randomized phase IIIb study. Arthritis Rheumatol. 2024 Mar 31. Baraliakos X, Østergaard M, Poddubnyy D, van der Heijde D, Deodhar A, Machado PM, Navarro-Compán V, Hermann KGA, Kishimoto M, Lee EY, Gensler LS, Kiltz U, Eigenmann MF, Pertel P, Readie A, Richards HB, Porter B, Braun J. PMID: 38556921.
      View in: PubMed   Mentions:    Fields:    
    2. Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies. Ann Rheum Dis. 2024 Jan 11; 83(2):199-213. Baraliakos X, Deodhar A, van der Heijde D, Magrey M, Maksymowych WP, Tomita T, Xu H, Massow U, Fleurinck C, Ellis AM, Vaux T, Shepherd-Smith J, Marten A, Gensler LS. PMID: 37793792.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature. Ann Rheum Dis. 2023 Dec 08. van der Heijde D, Molto A, Ramiro S, Braun J, Dougados M, van Gaalen FA, Gensler LS, Inman RD, Landewé RBM, Marzo-Ortega H, Navarro-Compán V, Phoka A, Poddubnyy D, Protopopov M, Reveille J, Rudwaleit M, Sampaio-Barros P, Sepriano A, Sieper J, Van den Bosch FE, van der Horst-Bruinsma I, Machado PM, Baraliakos X. PMID: 38071514.
      View in: PubMed   Mentions: 2     Fields:    
    4. Structural disease modification in axial spondyloarthritis. Best Pract Res Clin Rheumatol. 2023 09; 37(3):101898. Dinneen B, O'Shea F, Gensler L. PMID: 38042689.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Effet du sécukinumab versus adalimumab biosimilaire sur la progression radiographique chez les patients atteints de spondyloarthrite axiale radiographique : étude randomisée de phase 3b. Revue du Rhumatisme. 2023 Dec 1; 90:a168. Constantin CA, Baraliakos BX, Østergaard ØM, Poddubnyy PD, Van Der Heijde VD, Atul AD, Machado MP, Navarro-compán NV, Hermann HK, Kishimoto KM, Lee LE, Gensler GL, Kiltz KU, Eigenman EM, Pertel PP, Readie RA, Richards RH, Porter PB, Braun BJ. .
      View in: Publisher Site   Mentions:
    6. Tolérance et efficacité à long terme du bimékizumab chez les patients atteints de spondylarthrite ankylosante active : résultats à 5 ans d’une étude de phase IIb et de son extension en ouvert. Revue du Rhumatisme. 2023 Dec 1; 90:a186-a188. Dougados DM, Deodhar DA, Navarro-compán NV, Poddubnyy PD, Gensler GL, Ramiro RS, Tomita TT, Marzo-Ortega MH, Fleurinck FC, Vaux VT, Massow MU, Van Der Heijde VD, Baraliakos BX. .
      View in: Publisher Site   Mentions:
    7. Tolérance à long terme du bimékizumab chez les patients atteints de spondyloarthrite axiale (axSpA) et de rhumatisme psoriasique (RhPso) : résultats groupés des études de phase IIb/III. Revue du Rhumatisme. 2023 Dec 1; 90:a188-a189. Breban BM, Mease MP, Poddubnyy PD, Orbai OA, Warren WR, Fleurinck FC, Bajracharya BR, Ink IB, Massow MU, Shende SV, Sheperd-Smith SJ, Peterson PL, White WK, Landewé LR, Gensler GL. .
      View in: Publisher Site   Mentions:
    8. Effet du sécukinumab versus adalimumab biosimilaire sur la progression radiographique chez les patients atteints de spondyloarthrite axiale radiographique : analyse en sous-groupes avec sur le statut syndesmophytes et protéine C-réactive à l’inclusion. Revue du Rhumatisme. 2023 Dec 1; 90:a176. Roux RC, Poddubnyy PD, Van Der Heijde VD, Atul AD, Machado MP, Navarro-compán NV, Hermann HK, Kishimoto KM, Lee LE, Gensler GL, Kiltz KU, Eigenman EM, Pertel PP, Readie RA, Richards RH, Porter PB, Braun BJ, Baraliakos BX, Østergaard ØM. .
      View in: Publisher Site   Mentions:
    9. Faibles taux d’uvéites chez les patients atteints de spondyloarthrite axiale traités par bimékizumab : résultats regroupés des essais de phase IIb/III. Revue du Rhumatisme. 2023 Dec 1; 90:a178-a179. Dougados DM, Rudwaleit RM, Brown BM, Van Gaalen VF, Haroon HN, Gensler GL, Fleurinck FC, Marten MA, Massow MU, De Peyrecave DN, Vaux VT, White WK, Deodhar DA, Van Der Horst-Bruinsma VI. .
      View in: Publisher Site   Mentions:
    10. Comparative efficacy and safety of bimekizumab in axial spondyloarthritis: a systematic literature review and network meta-analysis. Rheumatology (Oxford). 2023 Nov 08. Deodhar A, Machado PM, Mørup M, Taieb V, Willems D, Orme M, Pritchett D, Gensler LS. PMID: 37947318.
      View in: PubMed   Mentions:    Fields:    
    11. Multimorbidity phenotypes in ankylosing spondylitis and their association with disease activity and functional impairment: Data from the prospective study of outcomes in ankylosing spondylitis cohort. Semin Arthritis Rheum. 2024 Feb; 64:152282. Karmacharya P, Crowson CS, Lennon RJ, Poudel D, Davis JM, Ogdie A, Liew JW, Ward MM, Ishimori M, Weisman MH, Brown MA, Rahbar MH, Hwang MC, Reveille JD, Gensler LS. PMID: 37995469; PMCID: PMC10872589.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Incidence Rate and Factors Associated With Fractures Among Medicare Beneficiaries With Ankylosing Spondylitis in the United States. Arthritis Care Res (Hoboken). 2024 Feb; 76(2):265-273. Stovall R, Kersey E, Li J, Baker R, Anastasiou C, Palmowski A, Schmajuk G, Gensler L, Yazdany J. PMID: 37605840; PMCID: PMC10843294.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Tofacitinib Efficacy and Safety in Patients With Ankylosing Spondylitis by Prior Biologic Disease-Modifying Antirheumatic Drug Use: A Post Hoc Analysis. ACR Open Rheumatol. 2023 Dec; 5(12):632-643. Deodhar A, Marzo-Ortega H, Wu J, Wang C, Dina O, Kanik KS, Fallon L, Gensler LS. PMID: 37775977; PMCID: PMC10716807.
      View in: PubMed   Mentions:
    14. 44261 Cutaneous tuberculosis at a US academic medical center: A retrospective review. Journal of the American Academy of Dermatology. 2023 Sep 1; 89(3):ab145. Gutierrez GR, Jacobson JR, Virji VA, Ghatnekar GS, Gensler GL, Schwartz SB, Haemel HA. .
      View in: Publisher Site   Mentions:
    15. 44092 Tuberculid reactions at a US academic medical center: A retrospective review. Journal of the American Academy of Dermatology. 2023 Sep 1; 89(3):ab244. Jacobson JR, Gutierrez GA, Virji VA, Ghatnekar GS, Schwartz SB, Gensler GL, Haemel HA. .
      View in: Publisher Site   Mentions:
    16. Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritis. Ther Adv Musculoskelet Dis. 2023; 15:1759720X231189079. Rudwaleit M, Machado PM, Taieb V, de Peyrecave N, Hoepken B, Gensler LS. PMID: 37663034; PMCID: PMC10469247.
      View in: PubMed   Mentions: 1  
    17. Tuberculid reactions: A multi-institution cohort study from 2 academic medical centers in the United States. JAAD Int. 2023 Dec; 13:68-70. Jacobson R, Gutierrez RA, Ghatnekar S, Virji AZ, Schwartz BS, Gensler LS, Haemel A, Frangos JE. PMID: 37711341; PMCID: PMC10498287.
      View in: PubMed   Mentions:
    18. Cutaneous tuberculosis: A multi-institution cohort study from 2 academic medical centers in the United States. JAAD Int. 2023 Dec; 13:63-65. Gutierrez RA, Jacobson R, Ghatnekar S, Virji AZ, Schwartz BS, Gensler LS, Haemel A, Frangos JE. PMID: 37700805; PMCID: PMC10493604.
      View in: PubMed   Mentions:
    19. Effect of Biologics in Subgroups of Axial Spondyloarthritis Based on Magnetic Resonance Imaging and C-Reactive Protein: A Systematic Review and Meta-Analysis. ACR Open Rheumatol. 2023 Sep; 5(9):481-489. Karmacharya P, Gupta S, Shahukhal R, Khanal R, Murad MH, Gensler LS. PMID: 37551049; PMCID: PMC10502854.
      View in: PubMed   Mentions:
    20. The association of psoriasis with rheumatic diseases: A national cross-sectional study. J Am Acad Dermatol. 2023 12; 89(6):1259-1261. Chung M, Liu J, Yeroushalmi S, Bartholomew E, Hakimi M, Gensler LS, Bhutani T, Liao W. PMID: 37549791.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. ASAS consensus definition of early axial spondyloarthritis. Ann Rheum Dis. 2023 Jun 15. Navarro-Compán V, Benavent D, Capelusnik D, van der Heijde D, Landewé RB, Poddubnyy D, van Tubergen A, Baraliakos X, Van den Bosch FE, van Gaalen FA, Gensler L, López-Medina C, Marzo-Ortega H, Molto A, Pérez-Alamino R, Rudwaleit M, van de Sande M, Sengupta R, Weber U, Ramiro S. PMID: 37321799.
      View in: PubMed   Mentions: 4     Fields:    
    22. SA50 Comparative Efficacy of Bimekizumab in Biologic/Targeted Synthetic DMARD-Naïve Patients with Axial Spondyloarthritis: Results from a Systematic Literature Review and Network Meta-Analysis. Value in Health. 2023 Jun 1; 26(6):s406. Deodhar DA, Machado MP, Mørup MM, Taieb TV, Willems WD, Orme OM, Stewart SD, Gensler GL. .
      View in: Publisher Site   Mentions:
    23. POS1115 EFFECT OF SECUKINUMAB VERSUS ADALIMUMAB BIOSIMILAR ON RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: SUBGROUP ANALYSES BY BASELINE SYNDESMOPHYTES AND C-REACTIVE PROTEIN STATUS. Annals of the Rheumatic Diseases. 2023 May 30; 82(Suppl 1):882.1-883. Baraliakos BX, Van der Heijde VD, Machado MP, Navarro-Compán NV, Gensler GL, Pertel PP, Quebe-Fehling QE, Readie RA, Richards RH, Poddubnyy PD. .
      View in: Publisher Site   Mentions:
    24. POS1103 BIMEKIZUMAB MAINTAINED IMPROVEMENTS IN EFFICACY ENDPOINTS AND HAD A CONSISTENT SAFETY PROFILE THROUGH 52 WEEKS IN PATIENTS WITH NON-RADIOGRAPHIC AND RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PARALLEL PHASE 3 STUDIES. Annals of the Rheumatic Diseases. 2023 May 30; 82(Suppl 1):873.2-874. Baraliakos BX, Deodhar DA, Van der Heijde VD, Magrey MM, Maksymowych MW, Tomita TT, Xu XH, Oortgiesen OM, Massow MU, Fleurinck FC, Ellis EA, Vaux VT, Smith SJ, Marten MA, Gensler GL. .
      View in: Publisher Site   Mentions:
    25. POS0668 LOW UVEITIS RATES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED WITH BIMEKIZUMAB: POOLED RESULTS FROM PHASE 2B/3 TRIALS. Annals of the Rheumatic Diseases. 2023 May 30; 82(Suppl 1):614.2-615. Rudwaleit RM, Brown BM, Van Gaalen VF, Haroon HN, Gensler GL, Fleurinck FC, Marten MA, Massow MU, De Peyrecave DN, Vaux VT, White WK, Deodhar DA, Van der Horst-Bruinsma VI. .
      View in: Publisher Site   Mentions:
    26. OP0059 EFFECT OF SECUKINUMAB VERSUS ADALIMUMAB BIOSIMILAR ON RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A RANDOMISED PHASE IIIB STUDY. Annals of the Rheumatic Diseases. 2023 May 30; 82(Suppl 1):38.2-40. Baraliakos BX, Østergaard ØM, Poddubnyy PD, Van der Heijde VD, Deodhar DA, Machado MP, Navarro-Compán NV, Hermann HK, Kishimoto KM, Lee LE, Gensler GL, Kiltz KU, Eigenmann EM, Pertel PP, Readie RA, Richards RH, Porter PB, Braun BJ. .
      View in: Publisher Site   Mentions:
    27. POS0683 AN EXPLORATORY ANALYSIS OF THE POTENTIAL DISCONNECT BETWEEN OBJECTIVE INFLAMMATORY RESPONSE AND CLINICAL RESPONSE FOLLOWING CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS. Annals of the Rheumatic Diseases. 2023 May 30; 82(Suppl 1):624-625. Rudwaleit RM, Van den Bosch VF, Marzo-Ortega MH, Navarro-Compán NV, Tham TR, Kumke KT, Bauer BL, Kim KM, Gensler GL. .
      View in: Publisher Site   Mentions:
    28. OP0055 ASAS CONSENSUS DEFINITION OF EARLY AXIAL SPONDYLOARTHRITIS. Annals of the Rheumatic Diseases. 2023 May 30; 82(Suppl 1):35.2-36. Navarro-Compán NV, Benavent BD, Capelusnik CD, Van der Heijde VD, Landewé LR, Poddubnyy PD, Van Tubergen VA, Baraliakos BX, Van den Bosch VF, Van Gaalen VF, Gensler GL, López-Medina LC, Marzo-Ortega MH, Moltó MA, Perez Alamino PR, Rudwaleit RM, Van de Sande VM, Sengupta SR, Weber WU, Ramiro RS. .
      View in: Publisher Site   Mentions:
    29. AB0937 TOFACITINIB EFFICACY AND SAFETY IN PATIENTS WITH ANKYLOSING SPONDYLITIS BY BASELINE C-REACTIVE PROTEIN LEVELS: A POST HOC ANALYSIS. Annals of the Rheumatic Diseases. 2023 May 30; 82(Suppl 1):1685.1-1685. Deodhar DA, Baraliakos BX, Magrey MM, Gensler GL, Thorat TA, Kinch KC, Pemmaraju PS, Cadatal CM, Nash NP. .
      View in: Publisher Site   Mentions:
    30. AB0938 SAFETY PROFILE OF BIMEKIZUMAB AT WEEK 16 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: RESULTS FROM FOUR PLACEBO-CONTROLLED PHASE 3 STUDIES. Annals of the Rheumatic Diseases. 2023 May 30; 82(Suppl 1):1686-1687. Poddubnyy PD, Gensler GL, Mease MP, Orbai OA, Warren WR, Ink IB, Massow MU, Assudani AD, Fleurinck FC, Shende SV, Smith SJ, Peterson PL, White WK, Landewé LR. .
      View in: Publisher Site   Mentions:
    31. POS0665 INCIDENCE RATE AND FACTORS ASSOCIATED WITH FRACTURES AMONG ADULTS WITH ANKYLOSING SPONDYLITIS IN THE UNITED STATES. Annals of the Rheumatic Diseases. 2023 May 30; 82(Suppl 1):612-613. Stovall SR, Kersey KE, LI LJ, Baker BR, Anastasiou AC, Palmowski PA, Schmajuk SG, Gensler GL, Yazdany YJ. .
      View in: Publisher Site   Mentions:
    32. Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis. Arthritis Res Ther. 2023 05 16; 25(1):80. Braun J, Blanco R, Marzo-Ortega H, Gensler LS, Van den Bosch F, Hall S, Kameda H, Poddubnyy D, van de Sande M, van der Heijde D, Zhuang T, Stefanska A, Readie A, Richards HB, Deodhar A. PMID: 37194094; PMCID: PMC10186767.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    33. E089 Effect of secukinumab on radiographic progression and inflammation in sacroiliac joints and spine in patients with non-radiographic axial spondyloarthritis: 2-year imaging outcomes from a Phase III randomised trial. Rheumatology. 2023 Apr 24; 62(Supplement_2). Marzo-Ortega MH, Braun BJ, Blanco BR, Gensler GL, van den Bosch vF, Hall HS, Kameda KH, Poddubnyy PD, van de Sande vM, van der Heidje vD, Zhuang ZT, Stefanska SA, Readie RA, Richards RH, Deodhar DA. .
      View in: Publisher Site   Mentions:
    34. Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries. Ann Rheum Dis. 2023 05; 82(5):698-709. Machado PM, Schäfer M, Mahil SK, Liew J, Gossec L, Dand N, Pfeil A, Strangfeld A, Regierer AC, Fautrel B, Alonso CG, Saad CGS, Griffiths CEM, Lomater C, Miceli-Richard C, Wendling D, Alpizar Rodriguez D, Wiek D, Mateus EF, Sirotich E, Soriano ER, Ribeiro FM, Omura F, Rajão Martins F, Santos H, Dau J, Barker JN, Hausmann J, Hyrich KL, Gensler L, Silva L, Jacobsohn L, Carmona L, Pinheiro MM, Zelaya MD, Severina MLÁ, Yates M, Dubreuil M, Gore-Massy M, Romeo N, Haroon N, Sufka P, Grainger R, Hasseli R, Lawson-Tovey S, Bhana S, Pham T, Olofsson T, Bautista-Molano W, Wallace ZS, Yiu ZZN, Yazdany J, Robinson PC, Smith CH. PMID: 36787993; PMCID: PMC10176347.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    35. Sleep Disturbance and SARS-CoV-2 Vaccinations in Patients With Chronic Inflammatory Disease. Arthritis Care Res (Hoboken). 2023 08; 75(8):1849-1856. Pawar N, Taylor KE, Yang M, Deepak P, Kim W, Paley MA, Matloubian M, Carvidi A, Ciorba MA, Demissie E, El-Qunni A, Huang K, Kinnett B, McMorrow LE, Paez D, Poole M, Rose A, Schriefer RE, Kim AHJ, Nakamura M, Katz P, Gensler LS. PMID: 36479599; PMCID: PMC9877722.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    36. Clinimetric Validation of the Assessment of Spondyloarthritis International Society Health Index in Patients With Radiographic Axial Spondyloarthritis in Ixekizumab Trials. J Rheumatol. 2023 06; 50(6):754-762. Kiltz U, van der Heijde D, Boonen A, Gensler LS, Gibble TH, Guo J, Carlier H, Braun J. PMID: 36725056.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    37. Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Ann Rheum Dis. 2023 04; 82(4):515-526. van der Heijde D, Deodhar A, Baraliakos X, Brown MA, Dobashi H, Dougados M, Elewaut D, Ellis AM, Fleurinck C, Gaffney K, Gensler LS, Haroon N, Magrey M, Maksymowych WP, Marten A, Massow U, Oortgiesen M, Poddubnyy D, Rudwaleit M, Shepherd-Smith J, Tomita T, Van den Bosch F, Vaux T, Xu H. PMID: 36649967; PMCID: PMC10086273.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    38. A simple point-of-care assay accurately detects anti-spike antibodies after SARS-CoV-2 vaccination. J Clin Virol Plus. 2023 Feb; 3(1):100135. Greene SE, Huang Y, Kim W, Liebeskind MJ, Chandrasekaran V, Liu Z, Deepak P, Paley MA, Lew D, Yang M, Matloubian M, Gensler LS, Nakamura MC, O'Hallaran JA, Presti RM, Whelan SPJ, Buchser WJ, Kim AHJ, Weil GJ. PMID: 36644774; PMCID: PMC9831968.
      View in: PubMed   Mentions:
    39. Virtually Speaking: The Impact of a Nationwide Synchronous and Asynchronous Learning Forum. Arthritis Care Res (Hoboken). 2023 07; 75(7):1563-1570. Dua AB, Bolster MB, Gensler LS, Kolfenbach J, Mamut MH, Seo P, Jonas BL. PMID: 35724301.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    40. Le bimékizumab améliore la fonction physique et la qualité de vie liée à l’état de santé chez les patients atteints de spondyloarthrite axiale : résultats de deux études de phase III. Revue du Rhumatisme. 2022 Dec 1; 89:a241-a242. Breban BM, Dubreuil DM, Gaffney GK, Gensler GL, Kay KJ, Navarro-Compán NV, De La Loge DC, Ellis EA, Fleurinck FC, Oortgiesen OM, Taieb TV, Deodhar DA. .
      View in: Publisher Site   Mentions:
    41. Taux de rétablissement de la réponse avec l’ixékizumab après l’arrêt du traitement chez des patients atteints de spondyloarthrite axiale : résultats à la semaine 104 d’une étude de retrait randomisé, contrôlée versus placebo. Revue du Rhumatisme. 2022 Dec 1; 89:a149. Landewé LR, Poddubnyy PD, Rahman RP, Bolce BR, Leage LS, Lisse LJ, Leung LA, Park PS, Gensler GL, Lukas LC. .
      View in: Publisher Site   Mentions:
    42. Le bimékizumab améliore les principaux symptômes rapportés par les patients atteints de spondylarthrite axiale, notamment les douleurs rachidiennes et la fatigue : résultats de deux études de phase III. Revue du Rhumatisme. 2022 Dec 1; 89:a239-a240. Dougados DM, Mease MP, Deodhar DA, Dubreuil DM, Magrey MM, Marzo-Ortega MH, Rudwaleit RM, De La Loge DC, Ellis EA, Fleurinck FC, Oortgiesen OM, Taieb TV, Gensler GL. .
      View in: Publisher Site   Mentions:
    43. Amélioration des signes et symptômes chez des patients atteints de spondyloarthrite axiale radiographique traités par bimékizumab : résultats à 24 semaines d’une étude de phase III, multicentrique, randomisée et contrôlée par placebo. Revue du Rhumatisme. 2022 Dec 1; 89:a132-a133. Dougados DM, Van Der Heijde VD, Baraliakos BX, Brown BM, Poddubnyy PD, Van Den Bosch VF, Haroon HN, Xu XH, Tomita TT, Gensler GL, Oortgiesen OM, Fleurinck FC, De Peyrecave DN, Vaux VT, Marten MA, Deodhar DA. .
      View in: Publisher Site   Mentions:
    44. Amélioration des signes et symptômes chez les patients atteints de spondyloathrite axiale non radiographique traités par le bimékizumab : résultats à 24 semaines d’une étude de phase III. Revue du Rhumatisme. 2022 Dec 1; 89:a138-a139. Breban BM, Deodhar DA, Van Der Heijde VD, Gensler GL, Xu XH, Gaffney GK, Dobashi DH, Maksymowych MW, Rudwaleit RM, Magrey MM, Elewaut ED, Oortgiesen OM, Fleurinck FC, De Peyrecave DN, Ellis EA, Vaux VT, Sheperd-Smith SJ, Baraliakos BX. .
      View in: Publisher Site   Mentions:
    45. The faecal microbiota is distinct in HLA-B27+ ankylosing spondylitis patients versus HLA-B27+ healthy controls. Clin Exp Rheumatol. 2023 May; 41(5):1096-1104. Stoll ML, Sawhney H, Wells PM, Sternes PR, Reveille JD, Morrow CD, Steves CJ, Brown MA, Gensler LS. PMID: 36441657.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Ixekizumab in radiographic axial spondyloarthritis with and without elevated C-reactive protein or positive magnetic resonance imaging. Rheumatology (Oxford). 2022 11 02; 61(11):4324-4334. Maksymowych WP, Bolce R, Gallo G, Seem E, Geneus VJ, Sandoval DM, Østergaard M, Tada K, Baraliakos X, Deodhar A, Gensler LS. PMID: 35188180; PMCID: PMC9629340.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    47. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023 01; 82(1):19-34. Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landewé RBM, Van den Bosch FE, Boteva B, Bremander A, Carron P, Ciurea A, van Gaalen FA, Géher P, Gensler L, Hermann J, de Hooge M, Husakova M, Kiltz U, López-Medina C, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compán V, Nissen MJ, Pimentel-Santos FM, Poddubnyy D, Proft F, Rudwaleit M, Telkman M, Zhao SS, Ziade N, van der Heijde D. PMID: 36270658.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    48. Why Do Some Patients Have Severe Sacroiliac Disease But No Syndesmophytes in Ankylosing Spondylitis? Data From a Nested Case-Control Study. J Rheumatol. 2023 03; 50(3):335-341. Ridley LK, Hwang MC, Reveille JD, Gensler LS, Ishimori ML, Brown MA, Rahbar MH, Tahanan A, Ward MM, Weisman MH, Learch TJ. PMID: 36182115.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    49. Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis. Nat Rev Rheumatol. 2022 11; 18(11):657-669. Stovall R, van der Horst-Bruinsma IE, Liu SH, Rusman T, Gensler LS. PMID: 36109666.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    50. Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study. Ann Rheum Dis. 2023 Feb; 82(2):212-216. Landewé RBM, Poddubnyy D, Rahman P, Van den Bosch FE, Bolce R, Liu Leage S, Lisse JR, Park SY, Gensler L. PMID: 36100350; PMCID: PMC9887347.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    51. Reactogenicity of the Messenger RNA SARS-CoV-2 Vaccines Associated With Immunogenicity in Patients With Autoimmune and Inflammatory Disease. Arthritis Care Res (Hoboken). 2022 12; 74(12):1953-1960. Yang MM, Taylor KE, Paez D, Carividi A, Demissie E, Pawar N, El-Qunni AA, McMorrow LE, Schriefer RE, Huang K, Kinnett B, Klebert M, Haile A, O'Halloran JA, Presti RM, Kim W, Ellebedy AH, Ciorba MA, Paley MA, Deepak P, Kim AHJ, Katz P, Matloubian M, Nakamura M, Gensler LS. PMID: 35412029; PMCID: PMC9073989.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    52. Correction: Stoll et al. Impact of HLA-B27 and Disease Status on the Gut Microbiome of the Offspring of Ankylosing Spondylitis Patients. Children 2022, 9, 569. Children (Basel). 2022 Aug 02; 9(8). Stoll ML, DeQuattro K, Li Z, Sawhney H, Weiss PF, Nigrovic PA, Wright TB, Schikler K, Edelheit B, Morrow CD, Reveille JD, Brown MA, Gensler LS. PMID: 36010158; PMCID: PMC9406925.
      View in: PubMed   Mentions: 1  
    53. Minimal Impact of the COVID-19 Pandemic on Disease Activity and Health-Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open-Label Extension Study. ACR Open Rheumatol. 2022 Sep; 4(9):819-824. Robinson PC, Machado PM, Haroon N, Gensler LS, Reveille JD, Taieb V, Vaux T, Fleurinck C, Oortgiesen M, de Peyrecave N, Deodhar A. PMID: 35833532; PMCID: PMC9349833.
      View in: PubMed   Mentions:
    54. Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study. Arthritis Rheumatol. 2022 Jul 13. Baraliakos X, Deodhar A, Dougados M, Gensler LS, Molto A, Ramiro S, Kivitz AJ, Poddubnyy D, Oortgiesen M, Vaux T, Fleurinck C, Shepherd-Smith J, de la Loge C, de Peyrecave N, van der Heijde D. PMID: 35829672.
      View in: PubMed   Mentions: 2     Fields:    
    55. Certolizumab Pegol Efficacy in Patients With Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status: An Analysis From the C-axSpAnd Study. ACR Open Rheumatol. 2022 Sep; 4(9):794-801. Robinson PC, Maksymowych WP, Gensler LS, Hall S, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, de Peyrecave N, Deodhar A. PMID: 35733363; PMCID: PMC9469479.
      View in: PubMed   Mentions: 1  
    56. Instrument selection for the ASAS core outcome set for axial spondyloarthritis. Ann Rheum Dis. 2023 06; 82(6):763-772. Navarro-Compán V, Boel A, Boonen A, Mease PJ, Dougados M, Kiltz U, Landewé RBM, Baraliakos X, Bautista-Molano W, Chiowchanwisawakit P, Dagfinrud H, Fallon L, Garrido-Cumbrera M, Gensler L, ElZorkany BK, Haroon N, Kwan YH, Machado PM, Maksymowych W, Molto A, de Peyrecave N, Poddubnyy D, Protopopov M, Ramiro S, Song IH, van Weely S, van der Heijde D. PMID: 35680390.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    57. POS0939 BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY. Annals of the Rheumatic Diseases. 2022 May 23; 81(Suppl 1):772-773. Deodhar DA, Van der Heijde VD, Gensler GL, Xu XH, Gaffney GK, Dobashi DH, Maksymowych MW, Rudwaleit RM, Magrey MM, Elewaut ED, Oortgiesen OM, Fleurinck FC, Ellis EA, Vaux VT, Smith SJ, Baraliakos BX. .
      View in: Publisher Site   Mentions:
    58. OP0023 A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING SECUKINUMAB 300 MG AND 150 MG AT WEEK 52 IN PATIENTS WITH ANKYLOSING SPONDYLITIS WHO DID NOT ACHIEVE INACTIVE DISEASE DURING AN INITIAL 16 WEEKS OF OPEN-LABEL TREATMENT WITH SECUKINUMAB 150 MG. Annals of the Rheumatic Diseases. 2022 May 23; 81(Suppl 1):16-17. Deodhar DA, Kivitz KA, Magrey MM, Walsh WJ, Mease MP, Greenwald GM, Calheiros CR, Kianifard KF, Elam EC, Nagar NK, Winseck WA, Gensler GL. .
      View in: Publisher Site   Mentions:
    59. OP0019 BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 2, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY. Annals of the Rheumatic Diseases. 2022 May 23; 81(Suppl 1):12-13. Van der Heijde VD, Baraliakos BX, Dougados DM, Brown BM, Poddubnyy PD, Van den Bosch VF, Haroon HN, Xu XH, Tomita TT, Gensler GL, Oortgiesen OM, Fleurinck FC, Vaux VT, Marten MA, Deodhar DA. .
      View in: Publisher Site   Mentions:
    60. POS0941 LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS. Annals of the Rheumatic Diseases. 2022 May 23; 81(Suppl 1):774-775. Robinson RP, Maksymowych MW, Gensler GL, Rudwaleit RM, Hoepken HB, Bauer BL, Kumke KT, Kim KM, Deodhar DA. .
      View in: Publisher Site   Mentions:
    61. OP0017 RECAPTURE RATES WITH IXEKIZUMAB AFTER WITHDRAWAL OF THERAPY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS AT WEEK 104 FROM A RANDOMIZED PLACEBO-CONTROLLED WITHDRAWAL STUDY. Annals of the Rheumatic Diseases. 2022 May 23; 81(Suppl 1):10-11. Landewé LR, Poddubnyy PD, Rahman RP, Bolce BR, Liu Leage LS, Lisse LJ, Leung LA, Park PS, Gensler GL. .
      View in: Publisher Site   Mentions:
    62. OP0154 COMORBIDITY CLUSTERS IN ANKYLOSING SPONDYLITIS AND THEIR ASSOCIATION WITH DISEASE ACTIVITY AND FUNCTIONAL IMPAIRMENT: DATA FROM THE PSOAS COHORT. Annals of the Rheumatic Diseases. 2022 May 23; 81(Suppl 1):100.2-100. Karmacharya KP, Crowson CC, Poudel PD, Davis DJ, Ogdie OA, Liew LJ, Ward WM, Ishimori IM, Weisman WM, Brown BM, Rahbar RM, Hwang HM, Reveille RJ, Gensler GL. .
      View in: Publisher Site   Mentions:
    63. POS0299 EFFECT OF SECUKINUMAB ON RADIOGRAPHIC PROGRESSION AND INFLAMMATION IN SACROILIAC JOINTS AND SPINE IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 2-YEAR IMAGING OUTCOMES FROM A PHASE III RANDOMISED TRIAL. Annals of the Rheumatic Diseases. 2022 May 23; 81(Suppl 1):397-398. Braun BJ, Blanco BR, Marzo-Ortega MH, Gensler GL, Van den Bosch VF, Hall HS, Kameda KH, Poddubnyy PD, Van de Sande VM, Van der Heijde VD, Zhuang ZT, Stefanska SA, Readie RA, Richards RH, Deodhar DA. .
      View in: Publisher Site   Mentions:
    64. COVID-19 Outcomes and Vaccination in Patients with Spondyloarthritis. Rheumatol Ther. 2022 Aug; 9(4):993-1016. Deodhar A, Bhana S, Winthrop K, Gensler LS. PMID: 35598255; PMCID: PMC9124289.
      View in: PubMed   Mentions: 1  
    65. Single Cell Transcriptome and Surface Epitope Analysis of Ankylosing Spondylitis Facilitates Disease Classification by Machine Learning. Front Immunol. 2022; 13:838636. Alber S, Kumar S, Liu J, Huang ZM, Paez D, Hong J, Chang HW, Bhutani T, Gensler LS, Liao W. PMID: 35634297; PMCID: PMC9135966.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    66. Identifying trajectories of radiographic spinal disease in ankylosing spondylitis: a 15-year follow-up study of the PSOAS cohort. Rheumatology (Oxford). 2022 05 05; 61(5):2079-2087. Hwang MC, Lee M, Gensler LS, Brown MA, Tahanan A, Rahbar MH, Hunter T, Shan M, Ishimori ML, Reveille JD, Weisman MH, Learch TJ. PMID: 34427579; PMCID: PMC9071538.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    67. Su1481: IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON ANTIBODY DECAY FOLLOWING MRNA VACCINATION TO SARS-COV-2 IN A PROSPECTIVE COHORT OF PATIENTS WITH CHRONIC INFLAMMATORY DISEASES. Gastroenterology. 2022 May 1; 162(7):s-592. Deepak DP, Kim KW, Paley PM, Yang YM, Burdess BS, Carvidi CA, Demissie DE, El-Qunni EA, Haile HA, Huang HK, Escudero EG, McMorrow ML, Paez PD, Pawar PN, Perantie PD, Schriefer SR, Sides SS, Thapa TM, Gergely GM, Akuse AS, Klebert KM, Mitchell ML, Nix NB, Graf GJ, Taylor TK, Chahin CS, Ciorba CM, Katz KP, Matloubian MM, O'Halloran OJ, Presti PR, Wu WG, Gensler GL, Nakamura NM, Ellebedy EA, Kim KA. .
      View in: Publisher Site   Mentions:
    68. Relationship Between Body Mass Index, Disease Activity, and Exercise in Ankylosing Spondylitis. Arthritis Care Res (Hoboken). 2022 08; 74(8):1287-1293. Liew JW, Gianfrancesco MA, Heckbert SR, Gensler LS. PMID: 33502113.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    69. Impact of HLA-B27 and Disease Status on the Gut Microbiome of the Offspring of Ankylosing Spondylitis Patients. Children (Basel). 2022 Apr 16; 9(4). Stoll ML, DeQuattro K, Li Z, Sawhney H, Weiss PF, Nigrovic PA, Wright TB, Schikler K, Edelheit B, Morrow CD, Reveille JD, Brown MA, Gensler LS. PMID: 35455612; PMCID: PMC9030797.
      View in: PubMed   Mentions: 4  
    70. Combined Single Cell Transcriptome and Surface Epitope Profiling Identifies Potential Biomarkers of Psoriatic Arthritis and Facilitates Diagnosis via Machine Learning. Front Immunol. 2022; 13:835760. Liu J, Kumar S, Hong J, Huang ZM, Paez D, Castillo M, Calvo M, Chang HW, Cummins DD, Chung M, Yeroushalmi S, Bartholomew E, Hakimi M, Ye CJ, Bhutani T, Matloubian M, Gensler LS, Liao W. PMID: 35309349; PMCID: PMC8924042.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    71. Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study. RMD Open. 2022 03; 8(1). van der Heijde D, Gensler LS, Maksymowych WP, Landewé R, Rudwaleit M, Bauer L, Kumke T, Kim M, Auteri SE, Hoepken B, Deodhar A. PMID: 35296532; PMCID: PMC8928377.
      View in: PubMed   Mentions: Translation:Humans
    72. Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial. Arthritis Care Res (Hoboken). 2022 03; 74(3):451-460. Walsh JA, Magrey MN, Baraliakos X, Inui K, Weng MY, Lubrano E, van der Heijde D, Boonen A, Gensler LS, Strand V, Braun J, Hunter T, Li X, Zhu B, León L, Calderon DMS, Kiltz U. PMID: 33044756; PMCID: PMC9306696.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    73. Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases. Lancet Gastroenterol Hepatol. 2022 03; 7(3):254-261. Guillo L, Abreu M, Panaccione R, Sandborn WJ, Azevedo VF, Gensler L, Moghaddam B, Ahuja V, Ali SA, Allez M, Ananthakrishnan AN, Bhattacharya A, Dubinsky M, Griffiths A, Hart A, Korelitz B, Kotze PG, Koutroubakis IE, Lakatos PL, Lindsay JO, Magro F, Mantzaris GJ, Ng SC, O'Morain C, Panés J, Parigi T, Ran Z, Rogler G, Rubin DT, Sachar DB, Siegmund B, Steinwurz F, Tysk C, Vavricka S, Verstraete SG, Brezin AP, Haemel AK, Dignass A, Sands BE, Danese S, Peyrin-Biroulet L. PMID: 35051383.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    74. Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Ther Adv Musculoskelet Dis. 2021; 13:1759720X211057975. Poddubnyy D, Baraliakos X, Van den Bosch F, Braun J, Coates LC, Chandran V, Diekhoff T, van Gaalen FA, Gensler LS, Goel N, Gottlieb AB, van der Heijde D, Helliwell PS, Hermann KGA, Jadon D, Lambert RG, Maksymowych WP, Mease P, Nash P, Proft F, Protopopov M, Sieper J, Torgutalp M, Gladman DD. PMID: 34987619; PMCID: PMC8721378.
      View in: PubMed   Mentions: 21  
    75. Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1. BMC Musculoskelet Disord. 2021 Dec 13; 22(1):1037. Braun J, Buehring B, Baraliakos X, Gensler LS, Porter B, Quebe-Fehling E, Haemmerle S. PMID: 34903218; PMCID: PMC8670267.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    76. A single center evaluation of applicant experiences in virtual interviews across eight internal medicine subspecialty fellowship programs. Med Educ Online. 2021 Dec; 26(1):1946237. Huppert LA, Hsu G, Elnachef N, Flint L, Frank JA, Gensler LS, Hsiao EC, Khanna RR, Qasim A, Schwartz BS, Widera E, Zapata C, Babik JM. PMID: 34187346; PMCID: PMC8253192.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    77. Poursuite ou arrêt du traitement par l’ixékizumab chez des patients atteints de spondyloarthrite axiale et ayant atteint la rémission : résultats d’une étude de retrait randomisé, contrôlée versus placebo. Revue du Rhumatisme. 2021 Dec 1; 88:a108-a109. Landewé LR, Gensler GL, Poddubnyy PD, Rahman RP, Hojnik HM, Li LX, Liu-Leage LS, Adams AD, Carlier CH, Van den Bosch VF, Lukas LC. .
      View in: Publisher Site   Mentions:
    78. Tolérance et efficacité à long terme du bimékizumab chez les patients atteints de spondylarthrite ankylosante : résultats à 3 ans d’une étude de phase IIb. Revue du Rhumatisme. 2021 Dec 1; 88:a261-a262. Van Der Heijde VD, Deodhar DA, Gensler GL, Poddubnyy PD, Kivitz KA, Dougados DM, De Peyrecave DN, Oortgiesen OM, Vaux VT, Fleurinck FC, Baraliakos BX. .
      View in: Publisher Site   Mentions:
    79. The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort. J Rheumatol. 2022 03; 49(3):274-280. Liew JW, Jafarzadeh SR, Dubreuil M, Heckbert SR, Mooney SJ, Brown MA, Ishimori ML, Reveille JD, Ward MM, Weisman MH, Gensler LS. PMID: 34853088; PMCID: PMC10404976.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    80. Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT. Arthritis Res Ther. 2021 09 04; 23(1):231. Braun J, Blanco R, Marzo-Ortega H, Gensler LS, van den Bosch F, Hall S, Kameda H, Poddubnyy D, van de Sande M, Wiksten AS, Porter BO, Shete A, Richards HB, Haemmerle S, Deodhar A. PMID: 34481517; PMCID: PMC8418044.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    81. Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort Study. Ann Intern Med. 2021 11; 174(11):1572-1585. Deepak P, Kim W, Paley MA, Yang M, Carvidi AB, Demissie EG, El-Qunni AA, Haile A, Huang K, Kinnett B, Liebeskind MJ, Liu Z, McMorrow LE, Paez D, Pawar N, Perantie DC, Schriefer RE, Sides SE, Thapa M, Gergely M, Abushamma S, Akuse S, Klebert M, Mitchell L, Nix D, Graf J, Taylor KE, Chahin S, Ciorba MA, Katz P, Matloubian M, O'Halloran JA, Presti RM, Wu GF, Whelan SPJ, Buchser WJ, Gensler LS, Nakamura MC, Ellebedy AH, Kim AHJ. PMID: 34461029; PMCID: PMC8407518.
      View in: PubMed   Mentions: 178     Fields:    
    82. The ASAS-OMERACT core domain set for axial spondyloarthritis. Semin Arthritis Rheum. 2021 12; 51(6):1342-1349. Navarro-Compán V, Boel A, Boonen A, Mease P, Landewé R, Kiltz U, Dougados M, Baraliakos X, Bautista-Molano W, Carlier H, Chiowchanwisawakit P, Dagfinrud H, de Peyrecave N, El-Zorkany B, Fallon L, Gaffney K, Garrido-Cumbrera M, Gensler LS, Haroon N, Kwan YH, Machado PM, Maksymowych WP, Poddubnyy D, Protopopov M, Ramiro S, Shea B, Song IH, van Weely S, van der Heijde D. PMID: 34489113.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    83. Repeated Spinal Mobility Measures and Their Association With Radiographic Damage in Ankylosing Spondylitis. ACR Open Rheumatol. 2021 Jun; 3(6):413-421. Hwang MC, Lee M, Gensler LS, Ward MM, Brown MA, Learch TJ, Tahanan A, Rahbar MH, Ishimori M, Weisman MH, Reveille JD, PSOAS Study Investigators. PMID: 34042330; PMCID: PMC8207687.
      View in: PubMed   Mentions:
    84. POS0904 FACTORS ASSOCIATED WITH SWITCHING FROM ONE ANTI-TNF AGENT TO ANOTHER ANTI-TNF, OR IL17 AGENT IN PATIENT WITH ANKYLOSING SPONDYLITIS. Annals of the Rheumatic Diseases. 2021 May 19; 80(Suppl 1):710.1-710. Hwang HM, Weisman WM, Gensler GL, Tahanan TA, Ishimori IM, Hunter HT, Bolce BR, Lisse LJ, Rahbar RM, Shan SM, Reveille RJ. .
      View in: Publisher Site   Mentions:
    85. POS0229 DISEASE ACTIVITY AND INFLAMMATION FOLLOWING WITHDRAWAL OF CERTOLIZUMAB PEGOL TREATMENT IN AXIAL SPONDYLOARTHRITIS PATIENTS WHO DID NOT EXPERIENCE FLARES DURING THE C-OPTIMISE STUDY. Annals of the Rheumatic Diseases. 2021 May 19; 80(Suppl 1):334-335. Gensler GL, Baraliakos BX, Bauer BL, Hoepken HB, Kumke KT, Kim KM, Landewé LR. .
      View in: Publisher Site   Mentions:
    86. POS0226 BIMEKIZUMAB LONG-TERM SAFETY AND EFFICACY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: 3-YEAR RESULTS FROM A PHASE 2B STUDY. Annals of the Rheumatic Diseases. 2021 May 19; 80(Suppl 1):332-333. Van der Heijde VD, Deodhar DA, Gensler GL, Poddubnyy PD, Kivitz KA, Dougados DM, De Peyrecave DN, Oortgiesen OM, Vaux VT, Fleurinck FC, Baraliakos BX. .
      View in: Publisher Site   Mentions:
    87. OP0255 THE ROLE OF PELVIC MORPHOLOGY IN AXIAL SPONDYLOARTHRITIS. Annals of the Rheumatic Diseases. 2021 May 19; 80(Suppl 1):156.1-156. Zaccagnino ZE, Patel PR, Gensler GL. .
      View in: Publisher Site   Mentions:
    88. POS0923 INFLUENCE OF BASELINE DEMOGRAPHICS ON IMPROVEMENTS IN DISEASE ACTIVITY MEASURES IN PATIENTS WITH ANKYLOSING SPONDYLITIS RECEIVING UPADACITINIB: A POST HOC SUBGROUP ANALYSIS OF SELECT-AXIS 1. Annals of the Rheumatic Diseases. 2021 May 19; 80(Suppl 1):722.2-723. Van den Bosch VF, Poddubnyy PD, Stigler SJ, Ostor OA, D’angelo DS, Navarro-Compán NV, Song SI, Gao GT, Ganz GF, Gensler GL. .
      View in: Publisher Site   Mentions:
    89. POS1255 REACTOGENICITY OF SARS-COV-2 VACCINES IN PATIENTS WITH AUTOIMMUNE AND INFLAMMATORY DISEASE. Annals of the Rheumatic Diseases. 2021 May 19; 80(Suppl 1):911.1-911. Yang YM, Katz KP, Paez PD, Carvidi CA, Matloubian MM, Nakamura NM, Gensler GL. .
      View in: Publisher Site   Mentions:
    90. Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y). Ann Rheum Dis. 2021 08; 80(8):1022-1030. Landewé RB, Gensler LS, Poddubnyy D, Rahman P, Hojnik M, Li X, Liu Leage S, Adams D, Carlier H, Van den Bosch F, COAST-Y study group. PMID: 33958326; PMCID: PMC8292566.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    91. Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study. Ann Rheum Dis. 2021 08; 80(8):1004-1013. Deodhar A, Sliwinska-Stanczyk P, Xu H, Baraliakos X, Gensler LS, Fleishaker D, Wang L, Wu J, Menon S, Wang C, Dina O, Fallon L, Kanik KS, van der Heijde D. PMID: 33906853; PMCID: PMC8292568.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCTClinical Trials
    92. Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis. Ann Rheum Dis. 2021 09; 80(9):1168-1174. Li Z, Wu X, Leo PJ, De Guzman E, Akkoc N, Breban M, Macfarlane GJ, Mahmoudi M, Marzo-Ortega H, Anderson LK, Wheeler L, Chou CT, Harrison AA, Stebbings S, Jones GT, Bang SY, Wang G, Jamshidi A, Farhadi E, Song J, Lin L, Li M, Wei JC, Martin NG, Wright MJ, Lee M, Wang Y, Zhan J, Zhang JS, Wang X, Jin ZB, Weisman MH, Gensler LS, Ward MM, Rahbar MH, Diekman L, Kim TH, Reveille JD, Wordsworth BP, Xu H, Brown MA, TCRI AS Group. PMID: 34161253; PMCID: PMC8364478.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    93. Glucocorticoids and B Cell Depleting Agents Substantially Impair Immunogenicity of mRNA Vaccines to SARS-CoV-2. medRxiv. 2021 Apr 09. Deepak P, Kim W, Paley MA, Yang M, Carvidi AB, El-Qunni AA, Haile A, Huang K, Kinnett B, Liebeskind MJ, Liu Z, McMorrow LE, Paez D, Perantie DC, Schriefer RE, Sides SE, Thapa M, Gergely M, Abushamma S, Klebert M, Mitchell L, Nix D, Graf J, Taylor KE, Chahin S, Ciorba MA, Katz P, Matloubian M, O'Halloran JA, Presti RM, Wu GF, Whelan SPJ, Buchser WJ, Gensler LS, Nakamura MC, Ellebedy AH, Kim AHJ. PMID: 33851176; PMCID: PMC8043473.
      View in: PubMed   Mentions: 1  
    94. Secukinumab Efficacy on Enthesitis in Patients With Ankylosing Spondylitis: Pooled Analysis of Four Pivotal Phase III Studies. J Rheumatol. 2021 08; 48(8):1251-1258. Schett G, Baraliakos X, Van den Bosch F, Deodhar A, Østergaard M, Gupta AD, Mpofu S, Fox T, Winseck A, Porter B, Shete A, Gensler LS. PMID: 33722947.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    95. Do geography and ethnicity play a role in juvenile Spondyloarthritis? A multi-center binational retrospective study. Pediatr Rheumatol Online J. 2021 Jan 06; 19(1):4. Ghantous N, Heshin-Bekenstein M, Dequattro K, Lakovsky Y, Hendel AM, Rappoport N, Aviel YB, Tirosh I, Harel L, Weiss PF, Gensler L, Mackenzie J, Amarilyo G. PMID: 33407634; PMCID: PMC7788991.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    96. Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies. Rheumatol Ther. 2021 Mar; 8(1):273-288. Baraliakos X, Van den Bosch F, Machado PM, Gensler LS, Marzo-Ortega H, Sherif B, Quebe-Fehling E, Porter B, Gaillez C, Deodhar A. PMID: 33351179; PMCID: PMC7991028.
      View in: PubMed   Mentions: 6  
    97. Le sécukinumab améliore les signes et symptômes de la spondyloarthrite axiale non radiographique : résultats d’une étude de phase III randomisée, contrôlée, stratifiée sur les signes objectifs d’inflammation à l’inclusion. Revue du Rhumatisme. 2020 Dec 1; 87:a175-a176. Goupille GP, Braun BJ, Blanco BR, Marzo-Ortega MH, Gensler GL, Van den Bosch VF, Kameda KH, Poddubnyy PD, Van De Sande VM, Wiksten WA, Porter PB, Moreno MS, Shete SA, Richards RH, Haemmerle HS, Deodhar DA. .
      View in: Publisher Site   Mentions:
    98. Efficacité et tolérance à 52 semaines de l’ixékizumab dans la spondyloarthrite axiale radiographique chez des patients en réponse inadéquate ou intolérants aux anti-TNF. Revue du Rhumatisme. 2020 Dec 1; 87:a167. Dougados DM, Sieper SJ, Baraliakos BX, Van den Bosch VF, Maksymowych MW, Ermann EJ, Li LX, Gallo GG, Carlier CH, Gensler GL, Lespessailles LE. .
      View in: Publisher Site   Mentions:
    99. Le genre, l’âge ou la sous-population influencent-ils le maintien de la rémission clinique dans la spondyloarthrite axiale après une réduction de la dose de certolizumab pegol?. Revue du Rhumatisme. 2020 Dec 1; 87:a170-a171. Landewé LR, Van Der Heijde VD, Dougados DM, Baraliakos BX, Van den Bosch VF, Gaffney GK, Bauer BL, Hoepken HB, De Peyrecave DN, Kumke KT, Gensler GL. .
      View in: Publisher Site   Mentions:
    100. Ixékizumab dans la spondyloarthrite axiale non-radiographique : résultats d’un essai de phase 3. Revue du Rhumatisme. 2020 Dec 1; 87:a165-a166. Deodhar DA, Van Der Heijde VD, Gensler GL, Kim KT, Maksymowych MW, Ostergaard OM, Poddubnyy PD, Marzo-Ortega MH, Bessette BL, Tomita TT, Gallo GG, Adams AD, Leung LA, Zhao ZF, Hojnik HM, Carlier CH, Sieper SJ, Dougados DM. .
      View in: Publisher Site   Mentions:
    101. Efficacité et sécurité d’emploi du bimekizumab dans la spondylarthrite ankylosante : résultats rapportés par les patients à 48 semaines dans une étude de phase IIb de détermination de la dose, randomisée, en double aveugle, contrôlée versus placebo. Revue du Rhumatisme. 2020 Dec 1; 87:a171-a172. Van Der Heijde VD, Gensler GL, Deodhar DA, Baraliakos BX, Poddubnyy PD, Kivitz KA, Farmer FM, Baeten BD, Goldammer GN, Coarse CJ, Oortgiesen OM, Dougados DM. .
      View in: Publisher Site   Mentions:
    102. Chronic back pain in first-degree relatives (FDRs) of patients with ankylosing spondylitis: predictive value of HLA-B27 and persistence of inflammatory back pain over time. RMD Open. 2020 11; 6(3). Doughem K, Weisman MH, Ward MM, Gensler LS, Ishimori M, Tahanan A, Kung DC, Diekman L, Lee M, Rahbar MH, Reveille JD. PMID: 33243782; PMCID: PMC7856153.
      View in: PubMed   Mentions: 2  Translation:Humans
    103. Nonsteroidal Antiinflammatory Drug Use and Association With Incident Hypertension in Ankylosing Spondylitis. Arthritis Care Res (Hoboken). 2020 11; 72(11):1645-1652. Liew JW, Ward MM, Reveille JD, Weisman M, Brown MA, Lee M, Rahbar M, Heckbert SR, Gensler LS. PMID: 31529687; PMCID: PMC7075727.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    104. Patient-reported Disease Activity in an Axial Spondyloarthritis Cohort during the COVID-19 Pandemic. ACR Open Rheumatol. 2020 Sep; 2(9):533-539. Liew JW, Castillo M, Zaccagnino E, Katz P, Haroon N, Gensler LS. PMID: 32893508; PMCID: PMC7504475.
      View in: PubMed   Mentions: 9  
    105. Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies. J Rheumatol. 2021 02; 48(2):188-197. Kiltz U, Wei JC, van der Heijde D, van den Bosch F, Walsh JA, Boonen A, Gensler LS, Hunter T, Carlier H, Dong Y, Li X, Bolce R, Strand V, Braun J. PMID: 32669450.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    106. The changing profile of ankylosing spondylitis in the biologic era. Clin Rheumatol. 2020 Sep; 39(9):2641-2651. Reveille JD, Lee M, Gensler LS, Ward MM, Hwang MC, Learch TJ, Tahanan A, Diekman L, Rahbar MH, Ishimori ML, Weisman MH. PMID: 32648102.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    107. Cardiovascular Risk Scores in Axial Spondyloarthritis Versus the General Population: A Cross-sectional Study. J Rheumatol. 2021 03; 48(3):361-366. Liew JW, Reveille JD, Castillo M, Sawhney H, Naovarat BS, Heckbert SR, Gensler LS. PMID: 32611668; PMCID: PMC7775278.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    108. AB1358-HPR DIAGNOSIS OF AXIAL SPONDYLOARTHRITIS: A PRIMARY UNMET EDUCATIONAL NEED FOR RHEUMATOLOGISTS. Annals of the Rheumatic Diseases. 2020 Jun 13; 79(Suppl 1):1966.2-1966. Maksymowych MW, Caplan CL, Deodhar DA, Dolatabadi DS, Hwang HM, Carlson CA, Steed SK, Carapellucci CA, Paschke PJ, Gensler GL. .
      View in: Publisher Site   Mentions:
    109. Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE. Rheumatol Ther. 2020 Sep; 7(3):581-599. Landewé R, van der Heijde D, Dougados M, Baraliakos X, Van den Bosch F, Gaffney K, Bauer L, Hoepken B, de Peyrecave N, Thomas K, Gensler LS. PMID: 32529495; PMCID: PMC7410911.
      View in: PubMed   Mentions: 6  
    110. Examining Treatment Decision-Making Among Patients With Axial Spondyloarthritis: Insights From a Conjoint Analysis Survey. ACR Open Rheumatol. 2020 Jul; 2(7):391-400. Joo W, Almario CV, Ishimori M, Park Y, Jusufagic A, Noah B, Gensler LS, Venuturupalli RS, Kay J, Weisman MH, Spiegel BMR. PMID: 32519467; PMCID: PMC7368141.
      View in: PubMed   Mentions: 6  
    111. Genomewide Association Study of Acute Anterior Uveitis Identifies New Susceptibility Loci. Invest Ophthalmol Vis Sci. 2020 06 03; 61(6):3. Huang XF, Li Z, De Guzman E, Robinson P, Gensler L, Ward MM, Rahbar MH, Lee M, Weisman MH, Macfarlane GJ, Jones GT, Klingberg E, Forsblad-d'Elia H, McCluskey P, Wakefield D, Coombes JS, Fiatarone Singh MA, Mavros Y, Vlahovich N, Hughes DC, Marzo-Ortega H, Van der Horste-Bruinsma I, O'Shea F, Martin TM, Rosenbaum J, Breban M, Jin ZB, Leo P, Reveille JD, Wordsworth BP, Brown MA. PMID: 32492107; PMCID: PMC7415282.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    112. THU0395 EFFICACY OF IXEKIZUMAB ON DISEASE ACTIVITY AND QUALITY OF LIFE IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AND OBJECTIVE SIGNS OF INFLAMMATION, STRATIFIED BY BASELINE CRP/SACROILIAC JOINT MRI STATUS. Annals of the Rheumatic Diseases. 2020 Jun 2; 79(Suppl 1):432-433. Maksymowych MW, Marzo-Ortega MH, ?stergaard ?M, Gensler GL, Ermann EJ, Deodhar DA, Poddubnyy PD, Sandoval SD, Bolce BR, Kronbergs KA, Liu Leage LS, Doridot DG, Geneus GV, Leung LA, Adams AD, Rudwaleit RM. .
      View in: Publisher Site   Mentions:
    113. OP0103 DOES GENDER, AGE OR SUBPOPULATION INFLUENCE THE MAINTENANCE OF CLINICAL REMISSION IN AXIAL SPONDYLOARTHRITIS FOLLOWING CERTOLIZUMAB PEGOL DOSE REDUCTION?. Annals of the Rheumatic Diseases. 2020 Jun 2; 79(Suppl 1):66.1-67. Landewé LR, Van der Heijde VD, Dougados DM, Baraliakos BX, Van den Bosch VF, Gaffney GK, Bauer BL, Hoepken HB, De Peyrecave DN, Thomas TK, Gensler GL. .
      View in: Publisher Site   Mentions:
    114. OP0105 EFFICACY AND SAFETY OF BIMEKIZUMAB IN ANKYLOSING SPONDYLITIS: 48-WEEK PATIENT-REPORTED OUTCOMES FROM A PHASE 2B, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY. Annals of the Rheumatic Diseases. 2020 Jun 2; 79(Suppl 1):68-69. Van der Heijde VD, Gensler GL, Deodhar DA, Baraliakos BX, Poddubnyy PD, Kivitz KA, Farmer FM, Baeten BD, Goldammer GN, Coarse CJ, Oortgiesen OM, Dougados DM. .
      View in: Publisher Site   Mentions:
    115. OP0106 SECUKINUMAB 150 MG SIGNIFICANTLY IMPROVED SIGNS AND SYMPTOMS OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM THE PHASE III PREVENT STUDY. Annals of the Rheumatic Diseases. 2020 Jun 2; 79(Suppl 1):69-70. Braun BJ, Blanco BR, Dokoupilova DE, Gensler GL, Kivitz KA, Hall HS, Kameda KH, Poddubnyy PD, Van de Sande VM, Van der Heijde VD, Wiksten WA, Porter PB, Richards RH, Haemmerle HS, Deodhar DA. .
      View in: Publisher Site   Mentions:
    116. OP0060 MACHINE LEARNING BASED BERLIN SCORING OF MAGNETIC RESONANCE IMAGES OF THE SPINE IN PATIENTS WITH ANKYLOSING SPONDYLITIS FROM THE MEASURE 1 STUDY. Annals of the Rheumatic Diseases. 2020 Jun 2; 79(Suppl 1):40-41. Jamaludin JA, Windsor WR, Ather AS, Kadir KT, Zisserman ZA, Braun BJ, Gensler GL, Machado MP, ?stergaard ?M, Poddubnyy PD, Coroller CT, Porter PB, Mpofu MS, Readie RA. .
      View in: Publisher Site   Mentions:
    117. THU0384 IMPACT OF IXEKIZUMAB ON WORK PRODUCTIVITY IN NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS PATIENTS: RESULTS FROM THE COAST-X TRIAL AT 52 WEEKS. Annals of the Rheumatic Diseases. 2020 Jun 2; 79(Suppl 1):426-426. Deodhar DA, Mease MP, Gensler GL, Rahman RP, Navarro-Compán NV, Marzo-Ortega MH, Hunter HT, Sandoval SD, Kronbergs KA, Zhu ZB, Leung LA, Strand SV. .
      View in: Publisher Site   Mentions:
    118. Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction. Ann Rheum Dis. 2020 07; 79(7):920-928. Landewé RB, van der Heijde D, Dougados M, Baraliakos X, Van den Bosch FE, Gaffney K, Bauer L, Hoepken B, Davies OR, de Peyrecave N, Thomas K, Gensler LS. PMID: 32381562; PMCID: PMC7307216.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    119. Propensity score matching/reweighting analysis comparing intravenous golimumab to infliximab for ankylosing spondylitis using data from the GO-ALIVE and ASSERT trials. Clin Rheumatol. 2020 Oct; 39(10):2907-2917. Gensler LS, Chakravarty SD, Cameron C, Peterson S, Spin P, Kafka S, Nair S, Deodhar A. PMID: 32367407; PMCID: PMC7497341.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    120. Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis. RMD Open. 2020 05; 6(1). Liew JW, Huang IJ, Louden DN, Singh N, Gensler LS. PMID: 32434828; PMCID: PMC7299511.
      View in: PubMed   Mentions: 7  Translation:Humans
    121. Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study. Ann Rheum Dis. 2020 05; 79(5):595-604. van der Heijde D, Gensler LS, Deodhar A, Baraliakos X, Poddubnyy D, Kivitz A, Farmer MK, Baeten D, Goldammer N, Coarse J, Oortgiesen M, Dougados M. PMID: 32253184; PMCID: PMC7213320.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCTClinical Trials
    122. EP38 Secukinumab provides sustained improvement of enthesitis in patients with ankylosing spondylitis: pooled analysis of four pivotal Phase 3 studies. Rheumatology. 2020 Apr 1; 59(Supplement_2). Barkham BN, Schett SG, Baraliakos BX, van den Bosch vF, Deodhar DA, Gensler GL, ?stergaard ?M, Agawane AS, Gupta GA, Mpofu MS, Fox FT, Winseck WA, Shete SA, Porter PB. .
      View in: Publisher Site   Mentions:
    123. P242 CZP improves work and household productivity and social participation over 1 year of treatment in patients with non-radiographic axSpA. Rheumatology. 2020 Apr 1; 59(Supplement_2). Gaffney GK, Deodhar DA, Gensler GL, Kay KJ, Maksymowych MW, Haroon HN, Landewé LR, Rudwaleit RM, Hall HS, Bauer BL, Hoepken HB, de Peyrecave dN, Kumke KT, van der Heijde vD. .
      View in: Publisher Site   Mentions:
    124. P284 Certolizumab pegol-treated patients with non-radiographic axSpA demonstrate improvements in sleep quality and other patient reported outcomes. Rheumatology. 2020 Apr 1; 59(Supplement_2). Sengupta SR, Gensler GL, Kay KJ, Maksymowych MW, Haroon HN, Bauer BL, Hoepken HB, de Peyrecave dN, Kumke KT, Deodhar DA. .
      View in: Publisher Site   Mentions:
    125. Longitudinal associations between depressive symptoms and clinical factors in ankylosing spondylitis patients: analysis from an observational cohort. Rheumatol Int. 2020 Jul; 40(7):1053-1061. Hwang MC, Lee MJ, Gensler LS, Ward MM, Brown MA, Eisen S, Learch TJ, Tahanan A, Rahbar MH, Ishimori ML, Weisman MH, Reveille JD. PMID: 32166439.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    126. Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review. Ther Adv Musculoskelet Dis. 2020; 12:1759720X20906040. Baraliakos X, Gensler LS, D'Angelo S, Iannone F, Favalli EG, de Peyrecave N, Auteri SE, Caporali R. PMID: 32180840; PMCID: PMC7057409.
      View in: PubMed   Mentions: 21  
    127. Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS). Clin Drug Investig. 2020 Mar; 40(3):269-278. Baraliakos X, Østergaard M, Gensler LS, Poddubnyy D, Lee EY, Kiltz U, Martin R, Sawata H, Readie A, Porter B, SURPASS Study Group. PMID: 31983056.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    128. A systematic review and network meta-analysis of current and investigational treatments for active ankylosing spondylitis. Clin Rheumatol. 2020 Aug; 39(8):2307-2315. Deodhar A, Chakravarty SD, Cameron C, Peterson S, Hensman R, Fogarty S, Spin P, Kafka S, Nair S, Gensler LS. PMID: 32107666; PMCID: PMC7338808.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    129. Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials. RMD Open. 2020 02; 6(1). Helliwell PS, Gladman DD, Chakravarty SD, Kafka S, Karyekar CS, You Y, Campbell K, Sweet K, Kavanaugh A, Gensler LS. PMID: 32209721; PMCID: PMC7046941.
      View in: PubMed   Mentions: 15  Translation:HumansCTClinical Trials
    130. Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial. Lancet. 2020 01 04; 395(10217):53-64. Deodhar A, van der Heijde D, Gensler LS, Kim TH, Maksymowych WP, Østergaard M, Poddubnyy D, Marzo-Ortega H, Bessette L, Tomita T, Leung A, Hojnik M, Gallo G, Li X, Adams D, Carlier H, Sieper J, COAST-X Study Group. PMID: 31813637.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCTClinical Trials
    131. A Terminal Event. Reply. N Engl J Med. 2019 11 28; 381(22):2183-2184. Lai AR, Gensler LS, McQuaid K. PMID: 31774977.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    132. A latent class based imputation method under Bayesian quantile regression framework using asymmetric Laplace distribution for longitudinal medication usage data with intermittent missing values. J Biopharm Stat. 2020; 30(1):160-177. Lee M, Rahbar MH, Gensler LS, Brown M, Weisman M, Reveille JD. PMID: 31730441; PMCID: PMC6957759.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    133. Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W). Ann Rheum Dis. 2020 02; 79(2):176-185. Dougados M, Wei JC, Landewé R, Sieper J, Baraliakos X, Van den Bosch F, Maksymowych WP, Ermann J, Walsh JA, Tomita T, Deodhar A, van der Heijde D, Li X, Zhao F, Bertram CC, Gallo G, Carlier H, Gensler LS, COAST-V and COAST-W Study Groups. PMID: 31685553; PMCID: PMC7025731.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    134. Assessing Physical Activity and Sleep in Axial Spondyloarthritis: Measuring the Gap. Rheumatol Ther. 2019 Dec; 6(4):487-501. Deodhar A, Gensler LS, Magrey M, Walsh JA, Winseck A, Grant D, Mease PJ. PMID: 31673975; PMCID: PMC6858410.
      View in: PubMed   Mentions: 8  
    135. Does psoriatic axial spondyloarthritis phenotype correlate with imaging morphotype? Clin Exp Rheumatol. 2020 Mar-Apr; 38(2):329-332. Gensler LS, Szumski A, Jones HE, Baraliakos X. PMID: 31577217.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    136. A Terminal Event. N Engl J Med. 2019 09 05; 381(10):970-976. Lai AR, Sheu L, Gensler LS, McQuaid K, Dhaliwal G. PMID: 31483969.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    137. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Rheumatol. 2019 10; 71(10):1599-1613. Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, Haroon N, Borenstein D, Wang R, Biehl A, Fang MA, Louie G, Majithia V, Ng B, Bigham R, Pianin M, Shah AA, Sullivan N, Turgunbaev M, Oristaglio J, Turner A, Maksymowych WP, Caplan L. PMID: 31436036; PMCID: PMC6764882.
      View in: PubMed   Mentions: 194     Fields:    Translation:Humans
    138. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Care Res (Hoboken). 2019 10; 71(10):1285-1299. Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, Haroon N, Borenstein D, Wang R, Biehl A, Fang MA, Louie G, Majithia V, Ng B, Bigham R, Pianin M, Shah AA, Sullivan N, Turgunbaev M, Oristaglio J, Turner A, Maksymowych WP, Caplan L. PMID: 31436026; PMCID: PMC6764857.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    139. Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts. Ann Rheum Dis. 2019 11; 78(11):1545-1549. Boel A, Molto A, van der Heijde D, Ciurea A, Dougados M, Gensler LS, Santos MJ, De Miguel E, Poddubnyy D, Rudwaleit M, van Tubergen A, van Gaalen FA, Ramiro S. PMID: 31362994.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    140. MR distribution of active inflammatory and chronic structural sacroiliac joint changes in axial spondyloarthropathy: Challenging conventional wisdom. Clin Imaging. 2019 Nov - Dec; 58:70-73. Motamedi D, Patel R, Devulapalli KK, Gensler LS, Steinbach L. PMID: 31252214.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    141. Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs. Drug Saf. 2019 Jun; 42(6):809. Ghosh S, Gensler LS, Yang Z, Gasink C, Chakravarty SD, Farahi K, Ramachandran P, Ott E, Strober BE. PMID: 31012051; PMCID: PMC6520476.
      View in: PubMed   Mentions: 3     Fields:    
    142. Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs. Drug Saf. 2019 06; 42(6):751-768. Ghosh S, Gensler LS, Yang Z, Gasink C, Chakravarty SD, Farahi K, Ramachandran P, Ott E, Strober BE. PMID: 30739254; PMCID: PMC6520311.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCTClinical Trials
    143. A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis. Arthritis Rheumatol. 2019 07; 71(7):1101-1111. Deodhar A, Gensler LS, Kay J, Maksymowych WP, Haroon N, Landewé R, Rudwaleit M, Hall S, Bauer L, Hoepken B, de Peyrecave N, Kilgallen B, van der Heijde D. PMID: 30848558; PMCID: PMC6619287.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    144. E098 Efficacy and safety outcomes in patients with axial spondyloarthritis treated with certolizumab pegol: results from the 48-week run-in part of a 96-week study (NCT02505542). Rheumatology. 2019 Apr 1; 58(Supplement_3). Landewe LR, van der Heijde vD, Dougados DM, Baraliakos BX, den Bosch dF, Gaffney GK, Hoepken HB, Thomas TK, Gensler GL. .
      View in: Publisher Site   Mentions:
    145. Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis. Best Pract Res Clin Rheumatol. 2018 06; 32(3):369-389. Liew JW, Ramiro S, Gensler LS. PMID: 31171309.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    146. Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis. Arthritis Rheumatol. 2019 02; 71(2):258-270. Deodhar A, Gensler LS, Sieper J, Clark M, Calderon C, Wang Y, Zhou Y, Leu JH, Campbell K, Sweet K, Harrison DD, Hsia EC, van der Heijde D. PMID: 30225992.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansCTClinical Trials
    147. Nonradiographic axial spondyloarthritis. Best Pract Res Clin Rheumatol. 2017 12; 31(6):816-829. Lockwood MM, Gensler LS. PMID: 30509442.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    148. Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial. Lancet. 2018 12 01; 392(10162):2378-2387. van der Heijde D, Baraliakos X, Gensler LS, Maksymowych WP, Tseluyko V, Nadashkevich O, Abi-Saab W, Tasset C, Meuleners L, Besuyen R, Hendrikx T, Mozaffarian N, Liu K, Greer JM, Deodhar A, Landewé R. PMID: 30360970.
      View in: PubMed   Mentions: 100     Fields:    Translation:HumansCTClinical Trials
    149. HLA class I and II alleles in susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2019 01; 78(1):66-73. Reveille JD, Zhou X, Lee M, Weisman MH, Yi L, Gensler LS, Zou H, Ward MM, Ishimori ML, Learch TJ, He D, Rahbar MH, Wang J, Brown MA. PMID: 30341055; PMCID: PMC6982366.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    150. Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis. Ann Rheum Dis. 2018 09; 77(9):1311-1317. Kiltz U, van der Heijde D, Boonen A, Akkoc N, Bautista-Molano W, Burgos-Vargas R, Wei JC, Chiowchanwisawakit P, Dougados M, Duruoz MT, Elzorkany BK, Gaydukova I, Gensler LS, Gilio M, Grazio S, Gu J, Inman RD, Kim TJ, Navarro-Compan V, Marzo-Ortega H, Ozgocmen S, Pimentel Dos Santos F, Schirmer M, Stebbings S, Van den Bosch FE, van Tubergen A, Braun J. PMID: 29858176.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    151. THU0242 Pregnancy outcomes and disease activity in women with axial spondyloarthritis: a systematic literature review. Annals of the Rheumatic Diseases. 2018 Jun 1; 77(Suppl 2):340. Moltó MA, Gensler GL, Clowse CM, Marzo-Ortega MH, Artignan AA, Goff-Leggett GD, Leonard LS, Resemann RH, Thurtle TE, de Peyrecave dN, Ecoffet EC, Förger FF. .
      View in: Publisher Site   Mentions:
    152. A multiple imputation method based on weighted quantile regression models for longitudinal censored biomarker data with missing values at early visits. BMC Med Res Methodol. 2018 01 11; 18(1):8. Lee M, Rahbar MH, Brown M, Gensler L, Weisman M, Diekman L, Reveille JD. PMID: 29325529; PMCID: PMC5765696.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    153. Successful treatment of mucous membrane pemphigoid with bortezomib. JAAD Case Rep. 2018 Jan; 4(1):81-83. Saeed L, Schmidt TH, Gensler LS, Gross AJ, Fox LP, Scharschmidt TC, Gaensler K, Naik H, Rosenblum MA, Shinkai K. PMID: 29387757; PMCID: PMC5771728.
      View in: PubMed   Mentions: 2  
    154. Opioid Analgesic Use in Patients with Ankylosing Spondylitis: An Analysis of the Prospective Study of Outcomes in an Ankylosing Spondylitis Cohort. J Rheumatol. 2018 02; 45(2):188-194. Dau JD, Lee M, Ward MM, Gensler LS, Brown MA, Learch TJ, Diekman LA, Tahanan A, Rahbar MH, Weisman MH, Reveille JD. PMID: 29196383; PMCID: PMC5805598.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    155. Clinical Images: Ochronotic arthropathy. Arthritis Rheumatol. 2017 11; 69(11):2208. Jafri K, Gensler LS, Link TM. PMID: 28622451.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    156. Ethnicity and disease severity in ankylosing spondylitis a cross-sectional analysis of three ethnic groups. Clin Rheumatol. 2017 Oct; 36(10):2359-2364. Jamalyaria F, Ward MM, Assassi S, Learch TJ, Lee M, Gensler LS, Brown MA, Diekman L, Tahanan A, Rahbar MH, Weisman MH, Reveille JD. PMID: 28780639; PMCID: PMC5693696.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    157. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis. 2018 01; 77(1):3-17. Smolen JS, Schöls M, Braun J, Dougados M, FitzGerald O, Gladman DD, Kavanaugh A, Landewé R, Mease P, Sieper J, Stamm T, Wit M, Aletaha D, Baraliakos X, Betteridge N, Bosch FVD, Coates LC, Emery P, Gensler LS, Gossec L, Helliwell P, Jongkees M, Kvien TK, Inman RD, McInnes IB, Maccarone M, Machado PM, Molto A, Ogdie A, Poddubnyy D, Ritchlin C, Rudwaleit M, Tanew A, Thio B, Veale D, Vlam K, van der Heijde D. PMID: 28684559; PMCID: PMC5754738.
      View in: PubMed   Mentions: 204     Fields:    Translation:Humans
    158. Validity and Responsiveness of a 10-Item Patient-Reported Measure of Physical Function in a Rheumatoid Arthritis Clinic Population. Arthritis Care Res (Hoboken). 2017 03; 69(3):338-346. Wahl E, Gross A, Chernitskiy V, Trupin L, Gensler L, Chaganti K, Michaud K, Katz P, Yazdany J. PMID: 27332620; PMCID: PMC6369925.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    159. Cervical Spinal Fracture and Other Diagnoses Associated With Mortality in Hospitalized Ankylosing Spondylitis Patients. Arthritis Care Res (Hoboken). 2017 Feb; 69(2):271-277. Wysham KD, Murray SG, Hills N, Yelin E, Gensler LS. PMID: 27159625; PMCID: PMC5102813.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    160. SAT0400 Clinical Factors Impacting Statin Usage in A Longitudinal Ankylosing Spondylitis Cohort. Annals of the Rheumatic Diseases. 2016 Jun 1; 75(Suppl 2):814. Dau DJ, Weisman WM, Lee LM, Ward WM, Brown BM, Diekman DL, Rahbar RM, Gensler GL, Reveille RJ. .
      View in: Publisher Site   Mentions:
    161. SAT0380 Nsaids Modify The Effect of Tumor Necrosis Factor Inhibitors on New Bone Formation in Ankylosing Spondylitis. Annals of the Rheumatic Diseases. 2016 Jun 1; 75(Suppl 2):805. Gensler GL, Reveille RJ, Ward WM, Brown BM, Rahbar RM, Lee LM, Weisman WM. .
      View in: Publisher Site   Mentions:
    162. FRI0398 Pharmacologic Therapy and Radiographic Progression in Ankylosing Spondylitis: A Growing Controversy. Annals of the Rheumatic Diseases. 2016 Jun 1; 75(Suppl 2):579. Gensler GL, Reveille RJ, Ward WM, Brown BM, Rahbar RM, Lee LM, Weisman WM. .
      View in: Publisher Site   Mentions:
    163. FRI0434 Prevalence of Structural Cardiac Disease and Diastolic Dysfunction in Axial Spondyloarthritis: A Prospective Case-Control Study. Annals of the Rheumatic Diseases. 2016 Jun 1; 75(Suppl 2):592. Reejhsinghani RR, Brown BK, Schiller SN, Yoon YG, Foster FE, Gensler GL. .
      View in: Publisher Site   Mentions:
    164. Physical activity in axial spondyloarthritis-tails from bench to bedside. Clin Rheumatol. 2016 Jun; 35(6):1443-5. Gensler LS. PMID: 27118200.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    165. ECHOCARDIOGRAPHIC EVALUATION OF CARDIOVASCULAR DISEASE IN ANKYLOSING SPONDYLITIS: A PROSPECTIVE CASE-CONTROL STUDY. Journal of the American College of Cardiology. 2016 Apr 1; 67(13):1659. Reejhsinghani RR, Brown BK, Schiller SN, Yoon YG, Gensler GL, Foster FE. .
      View in: Publisher Site   Mentions:
    166. National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia. PLoS One. 2016; 11(1):e0144918. Murray SG, Schmajuk G, Trupin L, Gensler L, Katz PP, Yelin EH, Gansky SA, Yazdany J. PMID: 26731012; PMCID: PMC4701172.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    167. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Care Res (Hoboken). 2016 Feb; 68(2):151-66. Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, Smith JA, Borenstein D, Hiratzka J, Weiss PF, Inman RD, Majithia V, Haroon N, Maksymowych WP, Joyce J, Clark BM, Colbert RA, Figgie MP, Hallegua DS, Prete PE, Rosenbaum JT, Stebulis JA, Van Den Bosch F, Yu DT, Miller AS, Reveille JD, Caplan L. PMID: 26401907; PMCID: PMC5123844.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    168. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Rheumatol. 2016 Feb; 68(2):282-98. Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, Smith JA, Borenstein D, Hiratzka J, Weiss PF, Inman RD, Majithia V, Haroon N, Maksymowych WP, Joyce J, Clark BM, Colbert RA, Figgie MP, Hallegua DS, Prete PE, Rosenbaum JT, Stebulis JA, van den Bosch F, Yu DT, Miller AS, Reveille JD, Caplan L. PMID: 26401991; PMCID: PMC5123840.
      View in: PubMed   Mentions: 157     Fields:    Translation:Humans
    169. Updates in adult-onset Still disease: Atypical cutaneous manifestations and associations with delayed malignancy. J Am Acad Dermatol. 2015 Aug; 73(2):294-303. Sun NZ, Brezinski EA, Berliner J, Haemel A, Connolly MK, Gensler L, McCalmont TH, Shinkai K. PMID: 26054431.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    170. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nat Commun. 2015 May 21; 6:7146. Cortes A, Pulit SL, Leo PJ, Pointon JJ, Robinson PC, Weisman MH, Ward M, Gensler LS, Zhou X, Garchon HJ, Chiocchia G, Nossent J, Lie BA, Førre Ø, Tuomilehto J, Laiho K, Bradbury LA, Elewaut D, Burgos-Vargas R, Stebbings S, Appleton L, Farrah C, Lau J, Haroon N, Mulero J, Blanco FJ, Gonzalez-Gay MA, Lopez-Larrea C, Bowness P, Gaffney K, Gaston H, Gladman DD, Rahman P, Maksymowych WP, Crusius JB, van der Horst-Bruinsma IE, Valle-Oñate R, Romero-Sánchez C, Hansen IM, Pimentel-Santos FM, Inman RD, Martin J, Breban M, Wordsworth BP, Reveille JD, Evans DM, de Bakker PI, Brown MA. PMID: 25994336; PMCID: PMC4443427.
      View in: PubMed   Mentions: 124     Fields:    Translation:Humans
    171. Axial spondyloarthritis: the heart of the matter. Clin Rheumatol. 2015 Jun; 34(6):995-8. Gensler LS. PMID: 25957880.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    172. ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients. Ann Rheum Dis. 2015 Aug; 74(8):1627-9. Robinson PC, Costello ME, Leo P, Bradbury LA, Hollis K, Cortes A, Lee S, Joo KB, Shim SC, Weisman M, Ward M, Zhou X, Garchon HJ, Chiocchia G, Nossent J, Lie BA, Førre Ø, Tuomilehto J, Laiho K, Jiang L, Liu Y, Wu X, Elewaut D, Burgos-Vargas R, Gensler LS, Stebbings S, Haroon N, Mulero J, Fernandez-Sueiro JL, Gonzalez-Gay MA, Lopez-Larrea C, Bowness P, Gafney K, Gaston JS, Gladman DD, Rahman P, Maksymowych WP, Xu H, van der Horst-Bruinsma IE, Chou CT, Valle-Oñate R, Romero-Sánchez MC, Hansen IM, Pimentel-Santos FM, Inman RD, Martin J, Breban M, Evans D, Reveille JD, Kim TH, Wordsworth BP, Brown MA. PMID: 25917849; PMCID: PMC4498996.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    173. Reply: To PMID 25154344. Arthritis Rheumatol. 2015 Mar; 67(3):856-7. Deodhar A, Sieper J, Reveille JD, van der Heijde D, Gensler LS, Landewé R, Spondyloarthritis Research and Treatment Network and Assessment of SpondyloArthritis international S. PMID: 25418880.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    174. Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis. Arthritis Rheumatol. 2015 Jan; 67(1):140-51. Robinson PC, Claushuis TA, Cortes A, Martin TM, Evans DM, Leo P, Mukhopadhyay P, Bradbury LA, Cremin K, Harris J, Maksymowych WP, Inman RD, Rahman P, Haroon N, Gensler L, Powell JE, van der Horst-Bruinsma IE, Hewitt AW, Craig JE, Lim LL, Wakefield D, McCluskey P, Voigt V, Fleming P, Spondyloarthritis Research Consortium of Canada, Australio-Anglo-American Spondylitis Consortium, In, Degli-Esposti M, Pointon JJ, Weisman MH, Wordsworth BP, Reveille JD, Rosenbaum JT, Brown MA. PMID: 25200001; PMCID: PMC4302162.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    175. 114 Clinical features of axial spondyloarthritis. . 2015 Jan 1; 946-950. Gensler GL. .
      View in: Publisher Site   Mentions:
    176. Spontaneous, drug-induced, and drug-free remission in peripheral and axial spondyloarthritis. Best Pract Res Clin Rheumatol. 2014 Oct; 28(5):807-18. Poddubnyy D, Gensler LS. PMID: 25488786; PMCID: PMC4289210.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    177. The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration's comments and concerns. Arthritis Rheumatol. 2014 Oct; 66(10):2649-56. Deodhar A, Reveille JD, van den Bosch F, Braun J, Burgos-Vargas R, Caplan L, Clegg DO, Colbert RA, Gensler LS, van der Heijde D, van der Horst-Bruinsma IE, Inman RD, Maksymowych WP, Mease PJ, Raychaudhuri S, Reimold A, Rudwaleit M, Sieper J, Weisman MH, Landewé RB. PMID: 25154344.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    178. New population-based reference values for spinal mobility measures based on the 2009-2010 National Health and Nutrition Examination Survey. Arthritis Rheumatol. 2014 Sep; 66(9):2628-37. Assassi S, Weisman MH, Lee M, Savage L, Diekman L, Graham TA, Rahbar MH, Schall JI, Gensler LS, Deodhar AA, Clegg DO, Colbert RA, Reveille JD. PMID: 24782356; PMCID: PMC4146670.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    179. Spine fractures in ankylosing spondylitis: a case report and review of imaging as well as predisposing factors to falls and fractures. Semin Arthritis Rheum. 2014 Aug; 44(1):20-4. Fatemi G, Gensler LS, Learch TJ, Weisman MH. PMID: 25087159; PMCID: PMC4121598.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    180. Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis. Ann Rheum Dis. 2015 Jul; 74(7):1387-93. Cortes A, Maksymowych WP, Wordsworth BP, Inman RD, Danoy P, Rahman P, Stone MA, Corr M, Gensler LS, Gladman D, Morgan A, Marzo-Ortega H, Ward MM, SPARCC (Spondyloarthritis Research Consortium of Canada), TASC (Australo-Anglo-American Spondyloarthritis Consortium), Learch TJ, Reveille JD, Brown MA, Weisman MH. PMID: 24651623; PMCID: PMC4470170.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    181. Development and validation of the spondyloarthritis radiography module for calibration of readers using the modified Stoke Ankylosing Spondylitis Spine Score. Arthritis Care Res (Hoboken). 2014 Jan; 66(1):55-62. Maksymowych WP, Learch T, Lambert RG, Ward M, Haroon N, Inman R, Salonen D, Gensler LS, Weisman MH. PMID: 23926089.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    182. The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum. 2013 Oct; 65(10):2645-54. Haroon N, Inman RD, Learch TJ, Weisman MH, Lee M, Rahbar MH, Ward MM, Reveille JD, Gensler LS. PMID: 23818109; PMCID: PMC3974160.
      View in: PubMed   Mentions: 196     Fields:    Translation:Humans
    183. MICA, a gene contributing strong susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2014 Aug; 73(8):1552-7. Zhou X, Wang J, Zou H, Ward MM, Weisman MH, Espitia MG, Xiao X, Petersdorf E, Mignot E, Martin J, Gensler LS, Scheet P, Reveille JD. PMID: 23727634; PMCID: PMC3874076.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    184. SAT0273 Lower socioeconomic status and smoking are associated with greater radiographic disease severity in axial spondyloarthritis. Annals of the Rheumatic Diseases. 2013 Jun 1; 71(Suppl 3):564. Gensler GL, Yoon YG, Learch LT, Ward WM. .
      View in: Publisher Site   Mentions:
    185. FRI0468 Socioeconomic status predicts radiographic progression in ankylosing spondylitis. Annals of the Rheumatic Diseases. 2013 Jun 1; 72(Suppl 3):a533. Gensler GL, Haroon HN, Reveille RJ, Learch LT, Brown BM, Weisman WM, Inman IR, Ward WM. .
      View in: Publisher Site   Mentions:
    186. Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative? Arthritis Care Res (Hoboken). 2013 Apr; 65(4):607-14. Bethi S, Dasgupta A, Weisman MH, Learch TJ, Gensler LS, Davis JC, Reveille JD, Ward MM. PMID: 23097327; PMCID: PMC3567248.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    187. Glucocorticoids: complications to anticipate and prevent. Neurohospitalist. 2013 Apr; 3(2):92-7. Gensler LS. PMID: 23983891; PMCID: PMC3726115.
      View in: PubMed   Mentions: 29  
    188. Neutrophilic urticaria with systemic inflammation: a case series. JAMA Dermatol. 2013 Apr; 149(4):453-8. Belani H, Gensler L, Bajpai U, Meinhardt E, Graf J, Pincus L, Leslie KS. PMID: 23715523.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    189. Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should question. Arthritis Care Res (Hoboken). 2013 Mar; 65(3):329-39. Yazdany J, Schmajuk G, Robbins M, Daikh D, Beall A, Yelin E, Barton J, Carlson A, Margaretten M, Zell J, Gensler LS, Kelly V, Saag K, King C, American College of Rheumatology Core Membership Group. PMID: 23436818; PMCID: PMC4106486.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    190. Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: differences in early and late disease. Arthritis Care Res (Hoboken). 2013 Feb; 65(2):257-65. Ward MM, Learch TJ, Gensler LS, Davis JC, Reveille JD, Weisman MH. PMID: 23042639; PMCID: PMC3541454.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    191. Is there a higher genetic load of susceptibility loci in familial ankylosing spondylitis? Arthritis Care Res (Hoboken). 2012 May; 64(5):780-4. Joshi R, Reveille JD, Brown MA, Weisman MH, Ward MM, Gensler LS, Wordsworth BP, Evans DM, Assassi S. PMID: 22231927; PMCID: PMC3335985.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    192. The "knowns" and "unknowns" of biologic therapy in ankylosing spondylitis. Am J Med Sci. 2012 May; 343(5):360-3. Gensler L, Inman R, Deodhar A. PMID: 22543538.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    193. Association of Sweet's Syndrome and Systemic Lupus Erythematosus. Case Rep Rheumatol. 2011; 2011:242681. Barton JL, Pincus L, Yazdany J, Richman N, McCalmont TH, Gensler L, Dall'era M, Fye KH. PMID: 22937442; PMCID: PMC3420725.
      View in: PubMed   Mentions: 4  
    194. 112 Clinical features of ankylosing spondylitis. Rheumatology. 2011 Jan 1; 1129-1134.e2. Gensler GL. .
      View in: Publisher Site   Mentions:
    195. Clinical, radiographic and functional differences between juvenile-onset and adult-onset ankylosing spondylitis: results from the PSOAS cohort. Ann Rheum Dis. 2008 Feb; 67(2):233-7. Gensler LS, Ward MM, Reveille JD, Learch TJ, Weisman MH, Davis JC. PMID: 17604288.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    196. Recognition and treatment of juvenile-onset spondyloarthritis. Curr Opin Rheumatol. 2006 Sep; 18(5):507-11. Gensler L, Davis JC. PMID: 16896291.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    197. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients. J Heart Lung Transplant. 2005 Nov; 24(11):1736-40. Kobashigawa JA, Moriguchi JD, Laks H, Wener L, Hage A, Hamilton MA, Cogert G, Marquez A, Vassilakis ME, Patel J, Yeatman L. PMID: 16297773.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    198. Clinical problem-solving. One surprise after another. N Engl J Med. 2005 Apr 07; 352(14):1474-9. Leeper NJ, Wener LS, Dhaliwal G, Saint S, Wachter RM. PMID: 15814884.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    199. Longitudinal study of vascular remodeling in coronary arteries after heart transplantation. J Heart Lung Transplant. 2000 Jun; 19(6):546-50. Kobashigawa J, Wener L, Johnson J, Currier JW, Yeatman L, Cassem J, Tobis J. PMID: 10867334.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    200. Does use of intravascular ultrasound accelerate arteriopathy in heart transplant recipients? Am Heart J. 1999 Aug; 138(2 Pt 1):358-63. Son R, Tobis JM, Yeatman LA, Johnson JA, Wener LS, Kobashigawa JA. PMID: 10426852.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Lianne's Networks
    Concepts (326)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (55)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.